BR112016026787A2 - - Google Patents
Info
- Publication number
- BR112016026787A2 BR112016026787A2 BR112016026787A BR112016026787A BR112016026787A2 BR 112016026787 A2 BR112016026787 A2 BR 112016026787A2 BR 112016026787 A BR112016026787 A BR 112016026787A BR 112016026787 A BR112016026787 A BR 112016026787A BR 112016026787 A2 BR112016026787 A2 BR 112016026787A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14168718 | 2014-05-16 | ||
PCT/EP2015/060653 WO2015173329A1 (en) | 2014-05-16 | 2015-05-13 | Antibacterial quinazoline-4(3h)-one derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016026787A2 true BR112016026787A2 (pt) | 2017-08-15 |
BR112016026787A8 BR112016026787A8 (pt) | 2017-12-26 |
Family
ID=50731968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016026787A BR112016026787A8 (pt) | 2014-05-16 | 2015-05-13 | Derivados de quinzaolina-4(3h)-ona antibacterianos |
Country Status (19)
Country | Link |
---|---|
US (1) | US9796686B2 (pt) |
EP (1) | EP3143007B1 (pt) |
JP (1) | JP2017515906A (pt) |
KR (1) | KR20170005105A (pt) |
CN (1) | CN106458931A (pt) |
AR (1) | AR100428A1 (pt) |
AU (1) | AU2015261540A1 (pt) |
BR (1) | BR112016026787A8 (pt) |
CA (1) | CA2948077A1 (pt) |
CL (1) | CL2016002918A1 (pt) |
EA (1) | EA201692305A1 (pt) |
ES (1) | ES2687040T3 (pt) |
IL (1) | IL248922A0 (pt) |
MX (1) | MX2016014989A (pt) |
PH (1) | PH12016502253A1 (pt) |
SG (1) | SG11201609286VA (pt) |
TW (1) | TW201625559A (pt) |
WO (1) | WO2015173329A1 (pt) |
ZA (1) | ZA201608680B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR097617A1 (es) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
MX360983B (es) | 2013-12-19 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Derivados antibacterianos de 1h-indazol y 1h-indol. |
AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
AR105646A1 (es) * | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
EP3341378A1 (en) * | 2015-08-28 | 2018-07-04 | Idorsia Pharmaceuticals Ltd | Antibacterial annulated pyrrolidin-2-one derivatives |
AR105889A1 (es) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
KR20180088456A (ko) * | 2015-12-08 | 2018-08-03 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 항박테리아 화합물로서의 치환된 벤자지논 |
IL295050A (en) | 2016-04-01 | 2022-09-01 | Recurium Ip Holdings Llc | Estrogen receptor modulators |
US10160724B2 (en) * | 2016-09-28 | 2018-12-25 | Dong-A St Co., Ltd. | Tetrahydropyridine derivatives and their use as antibacterial agents |
JP2022543832A (ja) | 2019-08-06 | 2022-10-14 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 変異体を治療するためのエストロゲン受容体調節剤 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0970046T3 (da) | 1997-02-27 | 2004-04-13 | Wyeth Corp | N-Hydroxy-2-(alkyl-, aryl- eller heteroarylsulfanyl, -sulfinyl eller -sulfonyl)-3-substituerede alkyl- eller heteroaryl-amider som matrixmetalloproteinaseinhibitorer |
EP3000810B1 (en) | 2002-03-13 | 2017-07-19 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivative as mek inhibitor |
CN107021895A (zh) * | 2007-06-12 | 2017-08-08 | 尔察祯有限公司 | 抗菌剂 |
JP5455913B2 (ja) | 2008-08-27 | 2014-03-26 | 大正製薬株式会社 | ナフチリジン−n−オキシドを有する新規ヒドロキサム酸誘導体 |
JP2012504556A (ja) | 2008-10-03 | 2012-02-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ウイルスポリメラーゼ阻害剤 |
DE102008044132A1 (de) | 2008-11-27 | 2010-06-02 | BSH Bosch und Siemens Hausgeräte GmbH | Kältegerät mit zweiseitig anschlagbarer Tür |
EP2432468A2 (en) | 2009-05-20 | 2012-03-28 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
WO2011045703A2 (en) | 2009-10-13 | 2011-04-21 | Pfizer Inc. | C-linked hydroxamic acid derivatives useful as antibacterial agents |
SI2512474T1 (sl) * | 2009-12-16 | 2014-12-31 | Pfizer Inc. | N-vezani derivati hidroksamske kisline, uporabni kot protibakterijska sredstva |
WO2012054332A1 (en) | 2010-10-18 | 2012-04-26 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
EA201390626A1 (ru) | 2010-11-10 | 2013-12-30 | Эйкеоджен, Инк. | Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций |
WO2012093809A2 (en) | 2011-01-03 | 2012-07-12 | Hanmi Pharm Co., Ltd. | New bicyclic compound for modulating g protein-coupled receptors |
MX341977B (es) * | 2011-03-07 | 2016-09-07 | Pfizer | Derivados de fluoro-piridinona utiles como agentes antibacterianos. |
CA2830866A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
US8748466B2 (en) | 2011-04-08 | 2014-06-10 | Pfizer Inc. | Isoxazole derivatives useful as antibacterial agents |
AU2012267622B2 (en) | 2011-06-08 | 2017-06-22 | Sunovion Pharmaceuticals, Inc. | Metabotropic glutamate receptor 5 modulators and methods of use thereof |
WO2013170030A1 (en) | 2012-05-09 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
WO2013170165A1 (en) * | 2012-05-10 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
US10647664B2 (en) | 2013-08-16 | 2020-05-12 | Duke University | Substituted hydroxamic acid compounds |
AR097617A1 (es) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
MX360983B (es) | 2013-12-19 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Derivados antibacterianos de 1h-indazol y 1h-indol. |
AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
-
2015
- 2015-05-13 WO PCT/EP2015/060653 patent/WO2015173329A1/en active Application Filing
- 2015-05-13 EP EP15722212.6A patent/EP3143007B1/en not_active Not-in-force
- 2015-05-13 EA EA201692305A patent/EA201692305A1/ru unknown
- 2015-05-13 SG SG11201609286VA patent/SG11201609286VA/en unknown
- 2015-05-13 JP JP2017512426A patent/JP2017515906A/ja not_active Ceased
- 2015-05-13 CA CA2948077A patent/CA2948077A1/en not_active Abandoned
- 2015-05-13 ES ES15722212.6T patent/ES2687040T3/es active Active
- 2015-05-13 AU AU2015261540A patent/AU2015261540A1/en not_active Abandoned
- 2015-05-13 BR BR112016026787A patent/BR112016026787A8/pt not_active Application Discontinuation
- 2015-05-13 MX MX2016014989A patent/MX2016014989A/es unknown
- 2015-05-13 CN CN201580024307.8A patent/CN106458931A/zh active Pending
- 2015-05-13 AR ARP150101482A patent/AR100428A1/es unknown
- 2015-05-13 KR KR1020167035088A patent/KR20170005105A/ko unknown
- 2015-05-13 US US15/311,758 patent/US9796686B2/en not_active Expired - Fee Related
- 2015-05-15 TW TW104115665A patent/TW201625559A/zh unknown
-
2016
- 2016-11-11 PH PH12016502253A patent/PH12016502253A1/en unknown
- 2016-11-13 IL IL248922A patent/IL248922A0/en unknown
- 2016-11-16 CL CL2016002918A patent/CL2016002918A1/es unknown
- 2016-12-15 ZA ZA2016/08680A patent/ZA201608680B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2017515906A (ja) | 2017-06-15 |
PH12016502253A1 (en) | 2017-01-16 |
SG11201609286VA (en) | 2016-12-29 |
BR112016026787A8 (pt) | 2017-12-26 |
EP3143007A1 (en) | 2017-03-22 |
MX2016014989A (es) | 2017-03-31 |
US20170081292A1 (en) | 2017-03-23 |
IL248922A0 (en) | 2017-01-31 |
EP3143007B1 (en) | 2018-07-11 |
ZA201608680B (en) | 2018-11-28 |
CN106458931A (zh) | 2017-02-22 |
ES2687040T3 (es) | 2018-10-23 |
AU2015261540A1 (en) | 2017-01-12 |
TW201625559A (zh) | 2016-07-16 |
CA2948077A1 (en) | 2015-11-19 |
EA201692305A1 (ru) | 2017-05-31 |
CL2016002918A1 (es) | 2017-04-07 |
KR20170005105A (ko) | 2017-01-11 |
WO2015173329A1 (en) | 2015-11-19 |
AR100428A1 (es) | 2016-10-05 |
US9796686B2 (en) | 2017-10-24 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |